Related Experiment Video
Updated: Jul 18, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
The prevalence of depression and anxiety in adults with Type 1 diabetes
M C Shaban1, J Fosbury, D Kerr
1Bournemouth Diabetes and Endocrine Centre, Royal Bournemouth Hospital, Bournemouth, UK. clare.shaban@rbch.nhs.uk
Aim:
The aim of the present study was to determine the prevalence of anxiety and depression in a large UK group of people with Type 1 diabetes.
Methods:
Patients aged 16-60 years were invited to complete self-report questionnaires when they attended outpatient clinic appointments. HbA(1c) was recorded from the clinic database.
Results:
Analysis was based on 273 complete questionnaires. The mean scores for both anxiety (mean 6.4, sd 4.5) and depression (mean 3.4, sd 3.5) were consistent with normative data. Females reported significantly higher mean anxiety than males, although neither reached the criterion for 'caseness'. Significant differences to the norm were observed for the percentages reporting moderate to severe levels of depression in males (chi(2) = 6.44; d.f. = 2; P = 0.04) and moderate to severe levels of anxiety in females (chi(2) = 7.47; d.f. = 2; P = 0.02). HbA(1c) was positively correlated with HADS scores (anxiety r = 0.2, P = 0.001, depression r = 0.14, P = 0.02).
Conclusions:
While there is no significant difference in the mean anxiety or depression in this cohort compared with those reported for a non-diabetic, healthy population, the results suggest that there is an increased prevalence of clinically relevant anxiety in females and of depression in males with Type 1 diabetes when compared with the normative data.
Related Concept Videos
Diabetes: Symptoms, Diagnosis, and Complications
Type I Diabetes I: Introduction
Psychoneuroimmunology: Diabetes and Cancer
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes III: Clinical Manifestations